Diethylcarbamazine contraindications: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) Created page with "__NOTOC__ {{Diethylcarbamazine}} {{CMG}} <ref>{{Cite web | last = | first = | title = WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Editi..." |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Contraindications== | |||
Not described.<ref>{{Cite web | last = | first = | title = WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Helminths: Lymphatic filariasis: Diethylcarbamazine | url = http://apps.who.int/medicinedocs/en/d/Jh2922e/3.5.1.html#Jh2922e.3.5.1 | publisher = | date = | accessdate = }}</ref> | |||
<ref>{{Cite web | last = | first = | title = WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Helminths: Lymphatic filariasis: Diethylcarbamazine | url = http://apps.who.int/medicinedocs/en/d/Jh2922e/3.5.1.html#Jh2922e.3.5.1 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== |
Latest revision as of 02:12, 7 January 2014
Diethylcarbamazine |
---|
HETRAZAN® WHO Prescribing Information |
Description |
Indications and Usage |
Contraindications |
Warnings and Precautions |
Adverse Reactions |
Overdosage |
Dosage and Administration |
How Supplied |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Contraindications
Not described.[1]
References
Adapted from the FDA Package Insert.